‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal

‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal
Rewind to 2013. Ebos’s chief executive, Mark Waller (right), and Symbion’s chief executive, Patrick Davies, come together to mark a $1.1b transaction. (Image: NZME)
Rebecca Stevenson
In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly voted for a $1.1 billion acquisition of pharmaceutical company Symbion, or Zuellig Healthcare Holdings Australia. This deal gave rise to a tagline Ebos still references today, as the largest diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It made Ebos then the third-largest listed company on the NZX, and a dual listing on the ASX followed la...

More Markets

Bulls, bears and analysis …
Opinion

Simon Robertson: Bulls, bears and analysis …

Why price-to-earnings ratios don’t cut it.

Simon Robertson 15 Nov 2025
NZ stocks take Wall Street lead to end down 1%
Markets Market Close

NZ stocks take Wall Street lead to end down 1%

The S&P/NZX 50 Index closed down 133.41 points or 0.98% at 13,464.46.

Jamie Gray 14 Nov 2025
Zoono says it knows no reason for share price surge, halt lifted
Markets

Zoono says it knows no reason for share price surge, halt lifted

A trading halt granted by the ASX to Australian-listed New Zealand antimicrobials manufacturer Zoono on Wednesday after a price query has been lifted after the company said it knew of no reason for its share price soaring.Its share price rose from 0.09c to 0.18c on volumes much h...

Denise McNabb 14 Nov 2025